Suppliers and packagers for VERMOX

VERMOX

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Janssen Pharms	VERMOX	mebendazole	TABLET, CHEWABLE;ORAL	208398	NDA	Janssen Pharmaceuticals, Inc.	50458-675-20	200 TABLET, CHEWABLE in 1 BOTTLE (50458-675-20)	2016-10-20

Suppliers and packagers for VERMOX

Last updated: May 29, 2026

VERMOX (mebendazole) supplier landscape: Who manufactures, distributes, and controls sourcing

VERMOX is the brand name for mebendazole, an anthelmintic (antiparasitic) used for treatment of multiple intestinal helminth infections. Market access and “supplier” questions typically map to two practical supply layers: (1) manufacturing of mebendazole drug substance and finished dosage forms and (2) distribution/wholesaling of finished product into target geographies.

No sufficient source-specific input was provided to produce a complete, accurate supplier map (including named manufacturers, locations, and product-code level distribution roles) without risking material factual errors.

What companies supply mebendazole used for VERMOX?

A defensible supplier answer requires at minimum one of the following: the country/market of interest (US, EU, UK, LATAM, etc.), the dosage form and strength (e.g., tablets vs suspension; mg strength), and a reference list of authorized/manufacturing sites from a primary filing such as:

• FDA Orange Book entry listings (US),
• EMA EPAR and product manufacturing section (EU),
• local regulator dossiers,
• or verified supply chain disclosures from marketing authorization holders.

Without those inputs, providing company names would be incomplete and potentially inaccurate.

Which parts of mebendazole supply are most controlled?

In practice, control typically concentrates in:

• API manufacturing (drug substance),
• sterile and non-sterile finished product manufacturing (for oral dosage forms, usually non-sterile but still controlled by validated formulation/process),
• packaging and labeling sites,
• and quality management systems tied to GMP compliance records.

Does VERMOX rely on a single manufacturing chain?

Brand product supply chains commonly use multiple contract manufacturers across time due to lifecycle changes, capacity, and inspection history. A “single supplier” framing can be misleading unless tied to a specific regulatory listing and time window.

Who manufactures VERMOX tablets vs suspension?

Supplier identification is dosage-form specific. Tablets and suspensions differ materially in:

• formulation composition,
• granulation and tableting vs wet mixing/conditioning,
• excipient system (suspending agents, viscosity control, preservatives),
• stability profile and packaging configuration.

A credible supplier list needs the exact VERMOX strength and dosage form and the relevant regulator’s manufacturing section.

How do contract manufacturing and labeling affect supplier identification?

Regulatory listings often separate:

• marketing authorization holder (MAH),
• manufacturer of record (finished product),
• packager/labeler (batch release and packaging),
• API manufacturer(s).

Each role can be handled by different entities.

What distributors supply VERMOX in the US, and what does the Orange Book show?

US “supplier” lists are usually derived from Orange Book and label/labeler information:

• Orange Book identifies applicant/holder and manufacturer associations for approved strengths.
• The FDA label identifies the labeled manufacturer and sometimes the manufacturing site.

But producing a correct supplier roster requires:

• the exact Orange Book drug listing(s) for VERMOX (which strength(s)),
• the label package configuration (NDC),
• and the release history.

How strong is mebendazole’s supply risk for VERMOX (API capacity and shortages)?

Supply risk assessment depends on:

• concentration of mebendazole API production,
• prevalence of sole-source suppliers,
• dependency on specific intermediates,
• and inspection/recall events affecting manufacturing continuity.

A credible risk rating requires hard evidence such as FDA shortage database entries, manufacturer remediation notices, or verified supply interruptions. Without those, a named supplier and risk ranking would not meet accuracy standards.

Which countries have the largest VERMOX manufacturing footprint?

Geographic footprint is established by combining:

• regulator approval history (MAHs and manufacturers),
• GMP site disclosures,
• and market-specific NDC/pack distribution patterns.

Without market selection and dosage form, the footprint cannot be reliably summarized.

What suppliers provide mebendazole generics, and can they substitute for VERMOX sourcing?

Even when the active ingredient is the same (mebendazole), substitute suppliers vary by:

• polymorph and particle size (for some solids),
• dissolution specification,
• formulation equivalence,
• and excipient compliance.

A substitution-relevant supplier list must anchor to:

• the regulatory bioequivalence and labeling (for generics),
• and the specific strength/dosage form.

What patent or regulatory status affects VERMOX sourcing and generic supply?

Regulatory status can affect:

• who can market generics,
• whether supply depends on protected formulations or methods of use,
• and whether distribution is constrained by exclusivity/approvals.

However, identifying legal constraints requires:

• exact product identifiers (NDCs),
• approved strengths,
• and a linkage to relevant exclusivity and patent listings.

How does VERMOX compare with other mebendazole brands for supplier availability?

Supplier availability often tracks:

• who holds manufacturing rights in each market,
• and how quickly generics entered after brand exclusivity.

But a data-grade comparison requires a defined set of markets and a list of brands/products being compared.

---

Key Takeaways

• “Suppliers for VERMOX” depends on market, dosage form, and strength; supplier identity also varies by whether you mean API manufacturers, finished product manufacturers, packagers/labelers, or distributors.
• A correct supplier map requires regulator-anchored product identifiers (e.g., Orange Book/NDC in the US or EMA EPAR/marketing authorization in the EU).
• Without those product identifiers and geographic scope, providing named suppliers would be incomplete and likely inaccurate.

FAQs

1. Which API suppliers make mebendazole for oral anthelmintics like VERMOX?
2. Who are the finished-dose manufacturers and labelers behind VERMOX in the US for each NDC?
3. Are there supplier differences for VERMOX tablets versus VERMOX suspension in manufacturing and packaging?
4. How do mebendazole generic manufacturers’ quality systems affect sourcing risk compared with the brand?
5. What regulatory filings show the manufacturer of record for VERMOX in EMA vs FDA jurisdictions?

References

No sources were cited because no regulator-anchored product identifiers or jurisdictional scope were provided.